Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GSK-3beta inhibition with CU-GTSM improves cognitive function in Alzheimer's disease model

Jan. 28, 2009

CLK-1 inhibition may explain the effect of clioquinol in neurodegenerative diseases

Jan. 28, 2009

EpiCept reports positive results from phase IIb EpiCept trial

Jan. 28, 2009

MAP completes patient enrollment in phase III clinical trial of MAP-0004

Jan. 27, 2009

Glenmark files phase I trial application with MHPRA for GRC-15300

Jan. 26, 2009

FDA approves Geron's IND for phase I clinical trial of GRNOPC-1 in spinal cord injury

Jan. 26, 2009

Cladribine significantly reduced relapse rate of MS in phase III pivotal trial

Jan. 26, 2009

Fenobam safe, affects behavior in patients with Fragile X syndrome

Jan. 26, 2009

Solvay claims novel cannabinoid CB1 receptor agonists for use as analgesic agents

Jan. 26, 2009

Novartis launches Extavia for multiple sclerosis

Jan. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...